Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lymphoma Study Association
2 parallel studies.
* For young patients (18-60 years): randomization between CHVP + interferon for 18 months and 4 CHOP followed by autotransplant after TBI
* For elderly patients (\>60 years): randomization between CHVP + interferon for 18 months and fludarabine 5 days every months for 6 months
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
study 1 (young patients): being less than 61 years old with a follicular lymphoma and needing to be treated because of high LDH level, high beta-2 microglobulin level, poor performance status, or large tumoral mass (lymph node \>7 cm, symptomatic splenomegaly, pleura effusion, or sign of compression by the tumor mass)
study 2 (elderly patients): being older than 60 years with a follicular lymphoma and needing to be treated because of high LDH level, high beta-2 microglobulin level, poor performance status, or large tumoral mass (lymph node \>7 cm, symptomatic splenomegaly, pleura effusion, or sign of compression by the tumor mass)
You may not be if
contra-indication to anthracycline or interferon
transformation into large cell lymphoma
previous treatment
localized stage without criteria of large tumor mass
patients HIV+
Clareo Health | Randomized Study for Patients With Follicular Lymphoma Needing Treatment
